Chemical industry – Page 70
-
BusinessPorous pills could be largest industrial 3D printing use
US grants first-of-a-kind approval for Aprecia’s epilepsy tablets exploiting porous structure
-
BusinessGreek crisis puts pressure on pharmaceuticals
Public spending cuts and capital restrictions on banks have exacerbated drug supply problems in Greece
-
BusinessNo one should be denied medication
Exclusive interview with Yusuf Hamied, chairman of Indian generic drugmaker Cipla
-
BusinessDeadly chemical blast at Chinese port
Explosion at warehouse in Tianjin kills at least 50 and injures hundreds, while ammonia leak sparks mass evacuations in Nanchong
-
Business
Shire makes hostile bid for Baxalta
Recently spun-out from Baxter, Baxalta is resisting the deal, saying it wants time to prove its true value
-
Business
Grabbing slices of the immuno-oncology pie
Another spate of immuno-oncology dealmaking adds to fervour in pharma’s ‘hottest space’
-
Business
Berry plastics to buy Avintiv for $2.5bn
Deal helps Berry diversify from food packaging into speciality medical materials
-
Business
AstraZeneca sells off drugs to streamline portfolio
Crohn’s disease and rare thyroid cancer drugs lie outside firm’s renewed strategic focus
-
Business
Lightweight composites drive Solvay to buy Cytec
$5.5bn deal launches Solvay into aerospace materials business
-
OpinionA precision instrument?
Chemists and biologists have different expectations when it comes to data, says Derek Lowe
-
Business
Celgene to buy immune-inflammatory specialist Receptos
$7.2bn deal further strengthens Celgene’s position in immunology
-
Business
Hikma boosts generics with Roxane buyout
Acquiring the Boehringer Ingelheim subsidiary expands Hikma’s presence in US generics market
-
Business
Allergan steps away from generics with sale to Teva
$40.5 billion deal gives Allergan cash to clear debt and fund further acquisitions, and catapults Teva into global pharma top 10
-
Business
Biogen to develop gene therapies with AGTC
$1bn deal gives Biogen rights to one clinical candidate and several earlier-stage programmes for rare eye diseases
-
Business
Three dead in Chinese petrochemical plant fire
Further four workers injured after leaking oil ignited at Qingyang Petrochemical plant in Gansu province
-
BusinessUS regulator says DuPont’s safety programme ‘failed’
The US Occupational Safety and Health Administration has again proposed to fine DuPont after uncovering ‘repeated’ and ‘serious’ lapses in the company’s worker safety programme
-
Opinion
Taking responsibility seriously
Companies have a duty to be proactive when it comes to sustainability
-
BusinessChemical firms seek better grasp of biomanufacturing
The search is on for better alternatives to the ‘broken’ way companies harness compound-making organisms
-
BusinessAn unsustainable hypocrisy
Social responsibility should extend through the whole supply chain, not just be a tool to put pressure on feedstock suppliers
-
NewsUS chemical industry lobby group in the hot seat again
Union of Concerned Scientists calls for greater transparency in the political activities of American Chemistry Council and member companies